Literature DB >> 26837675

Serum Troponin I Level for Diagnosis of Acute Coronary Syndrome in Patients with Chronic Kidney Disease.

Mehrdad Jafari Fesharaki, Saeed Alipour Parsa, Mohsen Nafar, Maryam Ghaffari-Rahbar, Fatemeh Omidi, Hamidreza Karimi-Sari1.   

Abstract

INTRODUCTION: Myocardial infarction is a common cause of mortality in patients with chronic kidney disease (CKD). Since troponins I and T levels rise in CKD patients without any myocardial cause, diagnostic value of cardiac troponins is not high in these patients. This study aimed to evaluate the value of troponin I and other cardiac biomarkers to differentiate acute coronary syndrome in CKD patients.
MATERIALS AND METHODS: In this cross-sectional study, patients with stage 3 to 5 of CKD with typical chest pain were enrolled. Troponins I and T and other biomarkers were measured, and angiography was carried out in these patients. Cardiac biomarkers and other variables were evaluated in patients and compared with angiography results.
RESULTS: Ninety CKD patients with a mean age of 61.67 ± 15.87 years were enrolled. Angiography results were normal in 48.9% of the patients, while it showed single-vessel disease in 14.5%, two-vessel disease in 23.3%, and three-vessel disease in 13.3%. Serum creatinine level, glomerular filtration rate, troponin I level, and creatine kinase level were not significantly different in patients with normal and abnormal angiography findings. The serum troponin I, creatine kinase, and creatine kinase-myocardial bound levels had no significant diagnostic values to differentiate abnormal angiography in CKD patients.
CONCLUSIONS: Serum levels of cardiac troponin I and creatine kinase-myocardial bound were not suitable to diagnose ACS in CKD patients (stages 3 to 5); therefore, we suggest using other diagnostic attempts in similar conditions. More evaluation is needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26837675

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  5 in total

1.  High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC study.

Authors:  Flavia Ballocca; Fabrizio D'Ascenzo; Claudio Moretti; Roberto Diletti; Carlo Budano; Alberto Palazzuoli; Matthew J Reed; Tullio Palmerini; Dariusz Dudek; Alfredo Galassi; Pierluigi Omedè; Nicolas M Mieghem; David Ferenbach; Marco Pavani; Diego Della Riva; Nick L Mills; Ron T Van Domburgh; Andrea Mariani; Artur Dziewierz; Marco di Cuia; Robert Jan van Geuns; Felix Zijlstra; Serena Bergerone; Sebastiano Marra; Giuseppe Biondi Zoccai; Fiorenzo Gaita
Journal:  Cardiol J       Date:  2017-03-10       Impact factor: 2.737

2.  Improving the diagnostic accuracy of acute myocardial infarction with the use of high-sensitive cardiac troponin T in different chronic kidney disease stages.

Authors:  Hongliu Yang; Jing Liu; Han Luo; Xiaoxi Zeng; Xi Tang; Liang Ma; Hongxia Mai; Shenju Gou; Fang Liu; Ping Fu
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

3.  Expression of miRNAs-122, -192 and -499 in end stage renal disease associated with acute myocardial infarction.

Authors:  Lobna Abdelsalam; Alshaymaa A Ibrahim; Aliaa Shalaby; Noha Osman; Assem Hashad; Dina Badawy; Hany Elghobary; Eman Amer
Journal:  Arch Med Sci       Date:  2019-08-08       Impact factor: 3.318

4.  Cardiorenal biomarkers: one step closer.

Authors:  Xiao-Jun Chen; Amir Lerman; Lilach O Lerman
Journal:  J Lab Precis Med       Date:  2017-05

5.  Assessment of Short-term, Within Hospital Cardiovascular Complications After Renal Transplantation in Baqiyatallah Hospital.

Authors:  Mohsen Sadeghi Ghahrodi; Behzad Einollahi; Amir Baharvand; Mohammad Javanbakht
Journal:  Mater Sociomed       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.